Stereotaxis Inc Share Price Nasdaq
Equities
US85916J4094
Advanced Medical Equipment & Technology
Sales 2024 * | 29.5M 2.46B | Sales 2025 * | 44.25M 3.69B | Capitalization | 172M 14.31B |
---|---|---|---|---|---|
Net income 2024 * | -19M -1.58B | Net income 2025 * | -16M -1.33B | EV / Sales 2024 * | 5.82 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.88 x |
P/E ratio 2024 * |
-8.89
x | P/E ratio 2025 * |
-11.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.12% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 29/16/29 | |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 01/03/01 |
Laura Garth
LAW | General Counsel | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 01/05/01 |
Chief Executive Officer | 57 | 29/16/29 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 03/17/03 |
1st Jan change | Capi. | |
---|---|---|
+12.85% | 227B | |
+13.88% | 192B | |
+18.39% | 136B | |
+28.78% | 108B | |
+1.67% | 64.07B | |
+18.24% | 52.1B | |
+7.04% | 51.87B | |
+10.83% | 44.33B | |
+5.94% | 36.75B |